These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 909077)
1. Renin inhibitory effect of 2-[4-(4'-chlorophenoxy)phenoxyacetylamino]-ethylphosphorylethanolamine (PE-104) in vitro and in vivo. Hosoki K; Miyazaki M; Yamamoto K J Pharmacol Exp Ther; 1977 Nov; 203(2):485-92. PubMed ID: 909077 [TBL] [Abstract][Full Text] [Related]
2. Renin inhibitory effect of synthetic phosphorylethanolamine (PE-104) in the rat. Miyazaki M; Yamamoto K; Hosoki K Clin Sci Mol Med Suppl; 1976 Dec; 3():89s-91s. PubMed ID: 1071718 [TBL] [Abstract][Full Text] [Related]
3. Renin inhibition by synthetic phosphatidyl and phosphorylethanolamines. Miyazaki M; Hosoki K; Yamamoto K Jpn Circ J; 1976 Aug; 40(8):901-10. PubMed ID: 966372 [TBL] [Abstract][Full Text] [Related]
4. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat]. Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423 [TBL] [Abstract][Full Text] [Related]
5. [In vitro and in vivo inhibition of renin by a thiazolylalanyl cyclostatine derivative]. Muneta S Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):865. PubMed ID: 2512401 [TBL] [Abstract][Full Text] [Related]
6. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Jensen J; Henik RA; Brownfield M; Armstrong J Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564 [TBL] [Abstract][Full Text] [Related]
7. Use of ameroid constrictors in the development of renin-dependent hypertension in dogs. Brooks DP; Fredrickson TA Lab Anim Sci; 1992 Feb; 42(1):67-9. PubMed ID: 1316513 [TBL] [Abstract][Full Text] [Related]
8. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF; Russell GI; Swales JD; Thurston H J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [TBL] [Abstract][Full Text] [Related]
9. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a potent inhibitor of subprimate and primate renins. Wood JM; Mah SC; Baum HP; de Gasparo M; Cumin F; Rüeger H; Nussberger J J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974 [TBL] [Abstract][Full Text] [Related]
11. Differential sympathetic and angiotensinergic responses in rats submitted to low- or high-salt diet. Carillo BA; Beutel A; Mirandola DA; Vidonho AF; Furukawa LN; Casarini D; Campos RR; Dolnikoff MS; Heimann JC; Bergamaschi CT Regul Pept; 2007 Apr; 140(1-2):5-11. PubMed ID: 17196676 [TBL] [Abstract][Full Text] [Related]
12. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys. Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs. Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882 [TBL] [Abstract][Full Text] [Related]
14. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin. Allan DR; Hui KY; Coletti C; Hollenberg NK J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383 [TBL] [Abstract][Full Text] [Related]
16. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist. Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure. Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609 [TBL] [Abstract][Full Text] [Related]
18. Renin inhibitors: their use in understanding the role of angiotensin II as a pressor hormone. Tree M; Szelke M; Leckie B; Atrash B; Donovan B; Hallett A; Jones DM; Lever AF; Morton JJ; Sueiras-Diaz J J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S49-52. PubMed ID: 2412013 [TBL] [Abstract][Full Text] [Related]
19. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system. Schalekamp MA; Derkx FH; van den Meiracker AH J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650 [TBL] [Abstract][Full Text] [Related]
20. An effect of extrarenal beta adrenergic stimulation on the release of renin. Reid IA; Schrier RW; Earley LE J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]